Cash Flow Statement
Quarterly Data
The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.
The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.
Paying user area
Try for free
AbbVie Inc. pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Common Stock Valuation Ratios
- Selected Financial Data since 2012
- Net Profit Margin since 2012
- Return on Assets (ROA) since 2012
- Price to Earnings (P/E) since 2012
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to AbbVie Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
AbbVie Inc., consolidated cash flow statement (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Net Earnings (Loss)
- The net earnings exhibit high volatility across the periods analyzed. Initially strong at $3,010 million in Q1 2020, the company experienced sharp fluctuations including losses such as -$739 million in Q2 2020 and near break-even or reduced earnings in multiple quarters thereafter. There is a general upward trend from early 2021 through 2023, although the gains are inconsistent with intermittent declines and a renewed loss recorded in early 2025.
- Depreciation and Amortization
- Depreciation expenses remain relatively stable around $180-$230 million per quarter, showing no significant long-term trend. Amortization of intangible assets is consistently a major expense, fluctuating mostly between approximately $1,800 million to $2,100 million quarterly, indicating ongoing amortization of acquired intangible assets.
- Deferred Income Taxes
- Deferred income taxes show considerable volatility with both negative and less negative balances, occasionally showing very large negative items, notably in Q4 2020 and Q4 2023, indicating significant variability in tax asset/liability recognition or temporary differences.
- Contingent Consideration Liabilities
- The change in fair value of contingent consideration liabilities is highly unstable, with large positive and negative swings across quarters, peaking at $4,675 million gain in Q4 2020 and significant drops thereafter. Payments of contingent consideration liabilities mostly appear in recent periods, with increasingly larger payments reaching nearly $549 million in Q4 2024, reflecting ongoing settlement of acquisition-related obligations.
- Stock-Based Compensation and Acquired IPR&D and Milestones
- Stock-based compensation fluctuates significantly but often stays within $100-$350 million quarterly with occasional spikes, reflecting variations in share-based payments. Acquisitions-related R&D (IPR&D) expenses show multiple spikes, notably in quarters such as Q2 2020 and significant increases in late 2023 and early 2025, signaling periods of strategic investment in development milestones or asset acquisitions.
- Other Charges and Gains
- One-time charges and gains such as gains on divestitures and other charges related to collaborations are sporadic, with no clear trend. Impairment of intangible assets displays several large outlays, especially in 2023 and 2025, indicating write-downs of assets. Non-cash litigation reserve adjustments fluctuate, reflecting irregular legal settlements or provisions.
- Working Capital Changes
- Accounts receivable and inventories show mixed trends with occasional negative changes suggesting collection or inventory reduction and positive swings indicating buildup. Accounts payable and other liabilities show volatile behavior with notable large positive inflows in several quarters implying cash preservation strategies or payment deferrals.
- Operating Cash Flows and Adjustments
- Cash flows from operating activities generally remain strong, with considerable quarterly variation but a tendency toward high inflows exceeding net earnings volatility. Adjustments to reconcile earnings to operating cash flow show large positive values especially in early periods, reflecting non-cash expenses and working capital effects.
- Investing Activities
- Investing cash flows reflect substantial outflows in some quarters, notably Q2 2020 and Q2 2024, mainly due to significant acquisitions of businesses. Property and equipment acquisitions are relatively steady but modest by comparison. Purchases and sales of investment securities vary, with an unusual large outflow in Q1 2022 followed by sales and maturities in subsequent periods.
- Financing Activities
- Cash flows from financing activities show marked negative values across most quarters, indicating net repayments and distributions over new borrowings. Noteworthy inflows occur sporadically from issuance of debt and short-term borrowings, counterbalanced by heavy repayments, large dividend payments growing gradually from around $1.7 billion to nearly $3 billion quarterly, and varying treasury stock purchases reflecting share repurchase programs.
- Exchange Rate and Net Cash Effects
- Effects of exchange rate changes on cash and equivalents generally remain minor but negative or positive in alternating quarters, contributing modestly to cash fluctuations. The net change in cash and equivalents is irregular, with periods of both significant increases and decreases, mirroring the underlying volatility in operating, investing, and financing cash flows.